熱門資訊> 正文
Corcept在内部收购价值超过300万美元后上涨
2026-03-20 23:00
- Corcept Therapeutics (CORT) traded higher on Friday after the company’s board member Leonard Baker Jr. disclosed that he purchased shares of the Korlym maker in a transaction worth more than $3M earlier this week.
- According to a regulatory filing on Thursday, Baker, Jr., who has been serving on the company's board as a director since 1999, has purchased 100,000 shares of Corcept (CORT) for an average price of about $33.14 apiece.
- The share purchases worth more than $3.3M have increased Baker Jr.'s direct ownership in the company by ~2% to ~1.1M shares.
- The purchases took place in two separate transactions on Tuesday, less than a month after an appeals court issued an unfavorable ruling against Corcept (CORT) in its patent dispute with Teva Pharmaceuticals (TEVA) related to Korlym.
More on Corcept Therapeutics
- Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript
- Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not
- Why Corcept Therapeutics' Relacorilant Fell Short And What It Means For The Company
- Mid-Cap healthcare stocks ranked by quant ratings after earnings season
- Corcept outlines $900M–$1B 2026 revenue guidance as relacorilant oncology approval nears
推薦文章
美股機會日報 | 特朗普再放豪言！正與伊朗談判，並收到伊方「大禮」；特斯拉機器人再迎新進展！馬斯克稱有望明年實現量產
一圖看懂 | 單季盈利承壓！拼多多Q4營收1239億元同比增12%，調后淨利卻下跌12%；高管稱「力爭三年再造一個拼多多」
財報前瞻 | 美團Q4財報將放榜！大摩、高盛逆勢力挺股價，當前美團已嚴重超跌？
中東戰火中金價狂瀉11%！創43年最慘周跌，避險邏輯崩塌還是黃金坑？
美股機會日報 | 中東硝煙將散？以官員稱美方4月9日結束對伊戰爭！海力士擬籌資百億赴美上市，豪擲80億美元鎖定阿斯麥光刻機！
一圖看懂 | 連續5個季度破千億！小米Q4營收1169億創歷史新高；淨利大增43.8%至63億元
無論美伊談判真假！華爾街已從特朗普引發的五分鍾狂飆獲得明確信號？
麥格理：緊張局勢緩和后布倫特原油底部在每桶85至90美元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
